Please login to the form below

Not currently logged in
Email:
Password:

Alpha-Plus joins Fishawack

UK-based Alpha-Plus Medical Communications has become part of the Fishawack Group of Companies

UK-based Alpha-Plus Medical Communications has become part of the Fishawack Group of Companies, an independent medical communications agency with offices in the UK and US.

Sarah Harding (formerly Clow) and George Clarkson, the founders of Alpha-Plus, explained: "We want to see Alpha-Plus grow and believe that we can achieve this most effectively as part of a larger group with the additional resources that this offers."

They added that both Fishawack and Alpha-Plus share a "closeness in business culture and a shared commitment to quality".

Oliver Dennis, CEO of Fishawack, said: "We acquired Nexus Communications in December last year; this latest deal is step two of a buy-and-build plan that will see Fishawack become recognised as the leading independent medical communications specialist. Clients want the dedication and personal service that they receive from a small agency, but with the resources of a large agency."

He continued: "The Fishawack Group of Companies gives them the best of both worlds, maintaining the small agency approach but with the combined strength and stability of a much larger organisation. We are very excited about Alpha-Plus joining the group."

Alpha-Plus will continue to trade as a separate brand within the group, but the companies will share resources where a cross over in delivery services permits.

22nd June 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics